These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30607758)

  • 1. Predicting Pharmacist Dispensing Practices and Comfort Related to Pre-exposure Prophylaxis for HIV Prevention (PrEP).
    Meyerson BE; Dinh PC; Agley JD; Hill BJ; Motley DN; Carter GA; Jayawardene W; Ryder PT
    AIDS Behav; 2019 Jul; 23(7):1925-1938. PubMed ID: 30607758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploratory survey of Florida pharmacists' experience, knowledge, and perception of HIV pre-exposure prophylaxis.
    Shaeer KM; Sherman EM; Shafiq S; Hardigan P
    J Am Pharm Assoc (2003); 2014; 54(6):610-7. PubMed ID: 25343624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV pre-exposure prophylaxis: Exploring the potential for expanding the role of pharmacists in public health.
    Okoro O; Hillman L
    J Am Pharm Assoc (2003); 2018; 58(4):412-420.e3. PubMed ID: 29789257
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Pharmacist's Expanding Role in HIV Pre-Exposure Prophylaxis.
    Farmer EK; Koren DE; Cha A; Grossman K; Cates DW
    AIDS Patient Care STDS; 2019 May; 33(5):207-213. PubMed ID: 31067124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding community pharmacist perceptions and knowledge about HIV preexposure prophylaxis (PrEP) therapy in a Mountain West state.
    Unni EJ; Lian N; Kuykendall W
    J Am Pharm Assoc (2003); 2016; 56(5):527-532.e1. PubMed ID: 27594106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient perspectives of pharmacists prescribing HIV pre-exposure prophylaxis: A survey of patients receiving antiretroviral therapy.
    Lutz S; Heberling M; Goodlet KJ
    J Am Pharm Assoc (2003); 2021; 61(2):e75-e79. PubMed ID: 33069595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Awareness, knowledge, and attitudes towards human immunodeficiency virus (HIV) pre-exposure prophylaxis (PrEP) among pharmacy students.
    Przybyla SM; Parks K; Bleasdale J; Sawyer J; Morse D
    Curr Pharm Teach Learn; 2019 Apr; 11(4):352-360. PubMed ID: 31040011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV pre-exposure prophylaxis awareness, practices, and comfort among urban and rural family medicine physicians.
    Owens C
    J Rural Health; 2023 Mar; 39(2):469-476. PubMed ID: 36337000
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacists as providers of HIV pre-exposure prophylaxis.
    Bruno C; Saberi P
    Int J Clin Pharm; 2012 Dec; 34(6):803-6. PubMed ID: 23073703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Midwest pharmacists' familiarity, experience, and willingness to provide pre-exposure prophylaxis (PrEP) for HIV.
    Broekhuis JM; Scarsi KK; Sayles HR; Klepser DG; Havens JP; Swindells S; Bares SH
    PLoS One; 2018; 13(11):e0207372. PubMed ID: 30427912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of pharmacist-led program on knowledge of college students about pre-exposure prophylaxis.
    Taliaferro T; Layson-Wolf C; Seung H; Banjo O; Tran D
    J Am Pharm Assoc (2003); 2021; 61(2):206-212.e2. PubMed ID: 33388259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting pharmacy naloxone stocking and dispensing following a statewide standing order, Indiana 2016.
    Meyerson BE; Agley JD; Davis A; Jayawardene W; Hoss A; Shannon DJ; Ryder PT; Ritchie K; Gassman R
    Drug Alcohol Depend; 2018 Jul; 188():187-192. PubMed ID: 29778772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Attitudes about community pharmacy access to HIV prevention medications in California.
    Koester KA; Saberi P; Fuller SM; Arnold EA; Steward WT
    J Am Pharm Assoc (2003); 2020; 60(6):e179-e183. PubMed ID: 32665097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient perception of community pharmacists prescribing pre-exposure prophylaxis for HIV prevention.
    Zhu V; Tran D; Banjo O; Onuegbu R; Seung H; Layson-Wolf C
    J Am Pharm Assoc (2003); 2020; 60(6):781-788.e2. PubMed ID: 32305210
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health Profession Students' Awareness, Knowledge, and Confidence Regarding Preexposure Prophylaxis: Results of a National, Multidisciplinary Survey.
    Bunting SR; Garber SS; Goldstein RH; Calabrese SK; Ritchie TD; Batteson TJ
    Sex Transm Dis; 2021 Jan; 48(1):25-31. PubMed ID: 32810029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparing for pre-exposure prophylaxis: perceptions and readiness of Canadian pharmacists for the implementation of HIV pre-exposure prophylaxis.
    Yoong D; Naccarato M; Sharma M; Wilton J; Senn H; Tan DH
    Int J STD AIDS; 2016 Jul; 27(8):608-16. PubMed ID: 26025254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Awareness and willingness towards pre-exposure prophylaxis against HIV infection among individuals seeking voluntary counselling and testing for HIV in Taiwan: a cross-sectional questionnaire survey.
    Lee YC; Chang SY; Lin KY; Chang LH; Liu WC; Wu CH; Sun HY; Hung CC; Chang SC
    BMJ Open; 2017 Oct; 7(10):e015142. PubMed ID: 29042372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Mixed Methods Evaluation of Pharmacists' Readiness to Provide Long-Acting Injectable HIV Pre-exposure Prophylaxis in California.
    Beltran RM; Hunter LA; Packel LJ; De Martini L; Holloway IW; Dong BJ; Lam J; McCoy SI; Ochoa AM
    J Acquir Immune Defic Syndr; 2024 Oct; 97(2):142-149. PubMed ID: 39250648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV Pre-exposure Prophylaxis (PrEP): Knowledge, attitudes and counseling practices among physicians in Germany - A cross-sectional survey.
    Sammons MK; Gaskins M; Kutscha F; Nast A; Werner RN
    PLoS One; 2021; 16(4):e0250895. PubMed ID: 33914824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Awareness, discussion and non-prescribed use of HIV pre-exposure prophylaxis among persons living with HIV/AIDS in Italy: a Nationwide, cross-sectional study among patients on antiretrovirals and their treating HIV physicians.
    Palummieri A; De Carli G; Rosenthal É; Cacoub P; Mussini C; Puro V;
    BMC Infect Dis; 2017 Nov; 17(1):734. PubMed ID: 29179700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.